PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
Ming‐Sound Tsao(University Health Network), Keith M. Kerr(Aberdeen Royal Infirmary), Mark Kockx(HistoGeneX (Belgium)), Mary-Beth Beasley(Mount Sinai Medical Center), Alain Borczuk(Cornell University), Johan Botling(Uppsala University), Lukas Bubendorf(University Hospital of Basel), Lucian R. Chirieac(Brigham and Women's Hospital), Gang Chen(Sun Yat-sen University), Teh‐Ying Chou(Taipei Veterans General Hospital), Jin-Haeng Chung(Seoul National University Bundang Hospital), Sanja Đačić(University of Pittsburgh), Sylvie Lantuéjoul(Centre Léon Bérard), Mari Mino–Kenudson(Harvard University), André L. Moreira(NYU Langone Health), Andrew G. Nicholson(National Health Service), Masayuki Noguchi(University of Tsukuba), Giuseppe Pelosi(University of Milan), Claudia Poleri(Medical Oncology Hematology Consultants), Prudence A. Russell(St Vincent's Health), Jennifer L. Sauter(Memorial Sloan Kettering Cancer Center), Erik Thunnissen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Hui Yu(University of Colorado Anschutz Medical Campus), Murry W. Wynes(International Association for the Study of Lung Cancer), Melania Pintilie(University Health Network), Yasushi Yatabe(Aichi Cancer Center), Fred R. Hirsch(International Association for the Study of Lung Cancer)
Cited by 799Open Access